Skip to main content
Figure 4 | Respiratory Research

Figure 4

From: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

Figure 4

Changes in St George's Respiratory Questionnaire symptom subscale scores. (a) Per-protocol end-of-treatment (PP EOT) population using a minimum clinically important difference (MCID) of 4 units; (b) PP EOT population using an MCID of 8 units; (c) intent-to-treat (ITT) population using an MCID of 4 units; (D) ITT population using an MCID of 8 units.

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us